Attached files
| file | filename |
|---|---|
| EX-10.9(A) - EX-10.9(A) - Corvus Pharmaceuticals, Inc. | a2234682zex-10_9a.htm |
| EX-32.1 - EX-32.1 - Corvus Pharmaceuticals, Inc. | a2234682zex-32_1.htm |
| EX-31.2 - EX-31.2 - Corvus Pharmaceuticals, Inc. | a2234682zex-31_2.htm |
| EX-31.1 - EX-31.1 - Corvus Pharmaceuticals, Inc. | a2234682zex-31_1.htm |
| EX-21.1 - EX-21.1 - Corvus Pharmaceuticals, Inc. | a2234682zex-21_1.htm |
| EX-10.9(B) - EX-10.9(B) - Corvus Pharmaceuticals, Inc. | a2234682zex-10_9b.htm |
| 10-K - 10-K - Corvus Pharmaceuticals, Inc. | a2234682z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-217102) and Form S-8 (No. 333-210456 and No. 333-216590) of Corvus Pharmaceuticals, Inc. of our report dated March 1, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/
PricewaterhouseCoopers LLP
San Jose, California
March 1, 2018
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM